Open AccessMetabolic syndrome in patients with psoriasis: A comparative study
Author(s) -
S. Lakshmi,
Amiya Kumar Nath,
Carounanidy Udayashankar
Publication year - 2014
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/2229-5178.131080
Subject(s) - psoriasis , medicine , dyslipidemia , metabolic syndrome , body mass index , psoriasis area and severity index , body surface area , proinflammatory cytokine , insulin resistance , dermatology , gastroenterology , obesity , inflammation
Psoriasis patients are at increased risk of developing the metabolic syndrome (MS). Proinflammatory cytokines such as tumor necrosis factor-α, interleukin-6 that are increased in the psoriatic plaques are known to contribute to features of MS such as hypertension, dyslipidemia and insulin resistance.